| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Medtronic Navigation is a Louisville, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sono Bello is a national leader in total body transformation providing micro-laser™ liposuction and customized, in-office facial rejuvenation procedures – which deliver incredible, natural-looking results.
Jones Regional Medical Center is a Anamosa, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Va Urology Ctr is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Henrico, VA. To find more information about Va Urology Ctr, please visit www.uro.com